Company Filing History:
Years Active: 1999-2002
Title: Philippe Camus: Innovator in Pharmaceutical Chemistry
Introduction
Philippe Camus is a notable inventor based in Muret, France. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of cannabinoid receptor antagonists. With a total of 3 patents to his name, Camus has established himself as a key figure in innovative drug development.
Latest Patents
Camus's latest patents include groundbreaking work on pyrazolecarboxylic acid derivatives. One of his notable inventions is the N-Piperidino-5-(4-bromophenyl)-1-(2,4-dichlorophenyl)-4-ethylpyrazole-3-carboxamide and its salts and solvates, which are recognized as powerful antagonists of the CB cannabinoid receptors. This compound is prepared by reacting a functional derivative of 5-(4-bromophenyl)-1-(2,4-dichlorophenyl)-4-ethylpyrazole-3-carboxylic acid with 1-aminopiperidine, optionally followed by salification. Additionally, he has developed a disubstituted glutarimide method for preparing glutarimides of formula (I), showcasing his innovative approach to pharmaceutical formulations.
Career Highlights
Philippe Camus has had a distinguished career, primarily working with Sanofi-Synthelabo, a leading global healthcare company. His work has focused on the synthesis and application of novel pharmaceutical compounds, contributing to advancements in medical treatments.
Collaborations
Throughout his career, Camus has collaborated with esteemed colleagues, including Marcel Descamps and Francis Barth. These partnerships have fostered a collaborative environment that enhances the innovation process in pharmaceutical research.
Conclusion
Philippe Camus is a prominent inventor whose work in pharmaceutical chemistry has led to significant advancements in drug development. His innovative patents and collaborations reflect his commitment to improving healthcare through scientific research.